Market News AIOpen the app

RNTX stock news · Rein Therapeutics, Inc.

Stories about Rein Therapeutics, Inc. (RNTX) from the last 90 days, each explained in plain English with whether the news reads good or bad for the company.

Get alerts for RNTX

Follow Rein Therapeutics, Inc. (RNTX) free. When we publish a story about it, you get the plain-English explanation as an alert.

Get alerts for RNTX
Free on the App Store and Google Play, or on the web.
  1. Nov 16, 2026, 8:39 AM ET · Trial

    Rein Therapeutics shared early results from its Phase 2 trial, showing promise for lung health in patients.

    Neutral

    Rein Therapeutics said 8 of 24 patients had improved lung function after 12 weeks, but the blinded groups were combined. The report does not show whether its drug works.